CD31 expression in plasmacytic/plasmablastic lesions

Annals of Diagnostic Pathology

Volumn 17, Issue 6, 2013, Pages 498-501

  Plocharczyk, Elizabeth ^a   Wakely, Paul E ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

CD31; Plasma cells; Plasmablastic lymphoma; Plasmablastic myeloma

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; TRANSCRIPTION FACTOR ERG; SDC1 PROTEIN, HUMAN; SYNDECAN 1; TUMOR MARKER;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; EXTRAOSSEOUS PLASMACYTOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PLASMA CELL; PLASMABLASTIC LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL DIFFERENTIATION; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; LARGE CELL LYMPHOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD31; CELL DIFFERENTIATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLASMA CELLS; PLASMACYTOMA; SYNDECAN-1; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84888006275     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.08.003     Document Type: Article

References (17)

1. P.J. Newman The role of PECAM-1 in vascular cell biology Ann N Y Acad Sci 714 1994 165 174
2. V.P. Lutzky, R.P. Carnevale, and M.J. Alvarez Platelet-endothelial cell adhesion molecule-1 (CD31) recycles and induces cell growth inhibition on human tumor cell lines J Cell Biochem 98 2006 1334 1350
3. W.A. Muller, S.A. Weigl, X. Deng, and D.M. Phillips PECAM-1 is required for transendothelial migration of leukocytes J Exp Med 178 1993 449 460
4. P.R. Greipp, T. Leong, and J.M. Bennett Plasmablastic morphology - an independent prognostic factor with clinical and laboratory correlates: ECOG Myeloma Trial E9486 report by the ECOG myeloma laboratory group Blood 91 1998 2501 2507
5. R.W. McKenna, R.A. Kyle, and W.M. Kuehl Plasma cell neoplasms S.H. Swerdlow, E. Campo, N.L. Harris, WHO classification of tumours of haematopoietic and lymphoid tissues 2008 IARC Lyon 200 213
6. J.K.C. Chan Tumors of the lymphoreticular system C.D.M. Fletcher, Diagnostic histopathology of tumors 3rd ed. 2007 Churchill Livingstone London 1139 1361
7. I.A. Lampert, S. Van Noorden, and A.C. Wotherspoon Centrocytoid plasma cells of the germinal center Appl Immunohistochem Mol Morphol 13 2005 124 131
8. F. Medina, C. Segundo, and J.A. Brieva Purification of human tonsil plasma cells: enrichment step by immunomagnetic selection of CD31+ cells Cytometry 39 2000 231 234
9. A. Vallario, M. Chilosi, and F. Adami Human myeloma cells express the CD38 ligand CD31 Br J Haematol 105 1999 441 444
10. S. Deaglio, and F. Malavasi The CD38/CD157 mammalian gene family: an evolutionary paradigm for other leukocyte surface enzymes Purinergic Signalling. 2 2006 431 441
11. J.E. Fernandez, S. Deaglio, and D. Donati Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues J Biol Regul Homeost Agents 12 1998 81 91
12. D. Govender, P. Harilal, and M. Dada CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells J Clin Pathol 50 1997 490 493
13. C.V. Hedvat, R.L. Comenzo, and J. Teruya-Feldstein Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma Br J Haematol 122 2003 728 744
14. J.K. McKenney, S.W. Weiss, and A.L. Folpe CD31 expression in intratumoral macrophages: a potential diagnostic pitfall Am J Surg Pathol 25 2001 1167 1173
15. S.A. Nicholson, M.B. McDermott, and B.R. DeYoung CD31 immunoreactivity in small round cell tumors Appl Immunohistochem Mol Morphol 8 2000 19 24
16. M. Miettinen, J.C. Fanburg-Smith, and M. Virolainen Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis Hum Pathol 30 1999 934 942
17. M. Miettinen, Z.F. Wang, and A. Paetau ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma Am J Surg Pathol 35 2011 432 441